Structure Database (LMSD)

LM_ID Common Name Systematic Name Main class Sub class Mass Formula
LMSP0501AD07 Manbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 971.73 C54H101NO13
LMSP05010108 N-(2R-hydroxy-heneicosanoyl)-1-beta-glucosyl-9-methyl-heptadecasphing-4E,8E-dienine Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 783.62 C45H85NO9
LMSP0501AD01 Manbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 861.62 C46H87NO13
LMSP05010114 N-(2R-hydroxy-heptadecanoyl)-1-beta-glucosyl-9-methyl-sphing-4E,8E-dienine Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 741.58 C42H79NO9
LMSP0501AD04 Manbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 945.71 C52H99NO13
LMSP0501AD05 Manbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 973.74 C54H103NO13
LMSP05010113 N-(2R-hydroxy-hexadecanoyl)-1-beta-glucosyl-9-methyl-sphing-4E,8E-dienine Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 727.56 C41H77NO9
LMSP0501AD08 Manbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 999.76 C56H105NO13
LMSP0501AD03 Manbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 917.68 C50H95NO13
LMSP05010112 N-(2R-hydroxy-octadecanoyl)-1-beta-glucosyl-9-methyl-sphing-4E,8E-dienine Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 755.59 C43H81NO9
LMSP0502AT01 Branched Forssman(d18:1/16:0) GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1794.96 C82H146N4O38
LMSP0502AT02 Branched Forssman(d18:1/18:0) GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1822.99 C84H150N4O38
LMSP0502AT03 Branched Forssman(d18:1/20:0) GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1851.02 C86H154N4O38
LMSP0502AT04 Branched Forssman(d18:1/22:0) GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1879.06 C88H158N4O38
LMSP0502AT05 Branched Forssman(d18:1/24:0) GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1907.09 C90H162N4O38
LMSP0502AT07 Branched Forssman(d18:1/24:1(15Z)) GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1905.07 C90H160N4O38
LMSP0502AT06 Branched Forssman(d18:1/26:0) GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1935.12 C92H166N4O38
LMSP0502AT08 Branched Forssman(d18:1/26:1(17Z)) GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1933.1 C92H164N4O38
LMSP0502AC01 Forssman antigen(d18:1/16:0) GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1429.83 C68H123N3O28
LMSP0502AC02 Forssman antigen(d18:1/18:0) GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1457.86 C70H127N3O28
LMSP0502AC03 Forssman antigen(d18:1/20:0) GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1485.89 C72H131N3O28
LMSP0502AC04 Forssman antigen(d18:1/22:0) GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1513.92 C74H135N3O28
LMSP0502AC05 Forssman antigen(d18:1/24:0) GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1541.95 C76H139N3O28
LMSP0502AC07 Forssman antigen(d18:1/24:1(15Z)) GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1539.94 C76H137N3O28
LMSP0502AC06 Forssman antigen(d18:1/26:0) GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1569.99 C78H143N3O28
LMSP0502AC08 Forssman antigen(d18:1/26:1(17Z)) GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1567.97 C78H141N3O28
LMSP0502AA01 Gb3(d18:1/16:0) Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1023.67 C52H97NO18
LMSP0502AA02 Gb3(d18:1/18:0) Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1051.7 C54H101NO18
LMSP0502AA03 Gb3(d18:1/20:0) Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1079.73 C56H105NO18
LMSP0502AA04 Gb3(d18:1/22:0) Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1107.76 C58H109NO18
LMSP0502AA05 Gb3(d18:1/24:0) Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1135.8 C60H113NO18
LMSP0502AA07 Gb3(d18:1/24:1(15Z)) Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1133.78 C60H111NO18
LMSP0502AA06 Gb3(d18:1/26:0) Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1163.83 C62H117NO18
LMSP0502AA08 Gb3(d18:1/26:1(17Z)) Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1161.81 C62H115NO18
LMSP0502AB01 Globoside I(d18:1/16:0) GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1226.75 C60H110N2O23
LMSP0502AB02 Globoside I(d18:1/18:0) GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1254.78 C62H114N2O23
LMSP0502AB03 Globoside I(d18:1/20:0) GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1282.81 C64H118N2O23
LMSP0502AB04 Globoside I(d18:1/22:0) GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1310.84 C66H122N2O23
LMSP0502AB05 Globoside I(d18:1/24:0) GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1338.88 C68H126N2O23
LMSP0502AB07 Globoside I(d18:1/24:1(15Z)) GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1336.86 C68H124N2O23
LMSP0502AB06 Globoside I(d18:1/26:0) GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1366.91 C70H130N2O23
LMSP0502AB08 Globoside I(d18:1/26:1(17Z)) GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1364.89 C70H128N2O23
LMSP0502AD01 Para-Forssman x3b(d18:1/16:0) GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1429.83 C68H123N3O28
LMSP0502AD02 Para-Forssman x3b(d18:1/18:0) GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1457.86 C70H127N3O28
LMSP0502AD03 Para-Forssman x3b(d18:1/20:0) GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1485.89 C72H131N3O28
LMSP0502AD04 Para-Forssman x3b(d18:1/22:0) GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1513.92 C74H135N3O28
LMSP0502AD05 Para-Forssman x3b(d18:1/24:0) GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1541.95 C76H139N3O28
LMSP0502AD07 Para-Forssman x3b(d18:1/24:1(15Z)) GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1539.94 C76H137N3O28
LMSP0502AD06 Para-Forssman x3b(d18:1/26:0) GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1569.99 C78H143N3O28
LMSP0502AD08 Para-Forssman x3b(d18:1/26:1(17Z)) GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1567.97 C78H141N3O28